Abpro Holdings, Inc. Cash Flow Conversion Efficiency
Abpro Holdings, Inc. cash flow conversion efficiency. Based on the latest financial reports, Abpro Holdings, Inc. (ABP) has a cash flow conversion efficiency ratio of 0.146x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.28 Million) by net assets ($-15.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Abpro Holdings, Inc. (2016–2024)
Cash flow conversion efficiency of Abpro Holdings, Inc. from 2016 to 2024. This chart illustrates how Abpro Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View ABP stock price and chart for real-time trading data and today's change.
Abpro Holdings, Inc. Cash Flow Conversion Ratio Explained
Abpro Holdings, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Abpro Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abpro Holdings, Inc. ranked by their cash flow conversion efficiency. Also see Abpro Holdings, Inc. (ABP) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Renold
LSE:RNO
|
0.166x |
|
East Coast Furnitech Public Company Limited
BK:ECF
|
-0.159x |
|
Camerit AG
F:RTML
|
-0.041x |
|
Collective Audience Inc.
NASDAQ:CAUD
|
0.868x |
|
Aditxt Inc.
NASDAQ:ADTX
|
0.130x |
|
Amatheon Agri Holding NV
PA:MLAAH
|
-0.204x |
|
UTime Limited
NASDAQ:WTO
|
0.019x |
|
Click Holdings Limited
NASDAQ:CLIK
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Abpro Holdings, Inc. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Abpro Holdings, Inc. from 2016 to 2024. Review ABP cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-14.95 Million | $-9.03 Million | 0.604x | +594.90% |
| 2023-12-31 | $-85.14 Million | $-7.40 Million | 0.087x | -26.45% |
| 2022-12-31 | $-75.73 Million | $-8.95 Million | 0.118x | +103.31% |
| 2021-12-31 | $3.07 Million | $-10.95 Million | -3.566x | -945.73% |
| 2017-12-31 | $-22.46 Million | $-9.47 Million | 0.422x | +6.67% |
| 2016-12-31 | $-12.35 Million | $-4.88 Million | 0.395x | -- |
About Abpro Holdings, Inc.
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in di… Read more